These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
417 related articles for article (PubMed ID: 26266392)
1. Interrelationships Between Ki67, HER2/neu, p53, ER, and PR Status and Their Associations With Tumor Grade and Lymph Node Involvement in Breast Carcinoma Subtypes: Retrospective-Observational Analytical Study. Shokouh TZ; Ezatollah A; Barand P Medicine (Baltimore); 2015 Aug; 94(32):e1359. PubMed ID: 26266392 [TBL] [Abstract][Full Text] [Related]
2. Study of ER, PR, HER2/neu, p53, and Ki67 expression in primary breast carcinomas and synchronous metastatic axillary lymph nodes. Khande TA; Joshi AR; Khandeparkar SGS; Kulkarni MM; Gogate BP; Kakade AR; Sahu PD; Khillare CD Indian J Cancer; 2020; 57(2):190-197. PubMed ID: 32445323 [TBL] [Abstract][Full Text] [Related]
3. Ki67 expression in breast cancer. Correlation with prognostic markers and clinicopathological parameters in Saudi patients. Elkablawy MA; Albasri AM; Mohammed RA; Hussainy AS; Nouh MM; Alhujaily AS Saudi Med J; 2016 Feb; 37(2):137-41. PubMed ID: 26837394 [TBL] [Abstract][Full Text] [Related]
4. Comparisons of p53, KI67 and BRCA1 expressions in patients with different molecular subtypes of breast cancer and their relationships with pathology and prognosis. Li Y; Zhang X; Qiu J; Pang T; Huang L; Zeng Q J BUON; 2019; 24(6):2361-2368. PubMed ID: 31983107 [TBL] [Abstract][Full Text] [Related]
5. Differential amplification and overexpression of HER-2/neu, p53, MIB1, and estrogen receptor/progesterone receptor among medullary carcinoma, atypical medullary carcinoma, and high-grade invasive ductal carcinoma of breast. Xu R; Feiner H; Li P; Yee H; Inghirami G; Delgado Y; Perle MA Arch Pathol Lab Med; 2003 Nov; 127(11):1458-64. PubMed ID: 14567723 [TBL] [Abstract][Full Text] [Related]
6. Hormonal Receptor, Human Epidermal Growth Factor and Its Association with Breast Cancer Tumor Characteristics in Albania. Pajenga E; Rexha T; Çeliku S; Ugrinska A; Bejtja G Cent Eur J Public Health; 2016 Sep; 24(3):171-175. PubMed ID: 27760283 [TBL] [Abstract][Full Text] [Related]
7. Male breast carcinoma: correlation of ER, PR, Ki-67, Her2-Neu, and p53 with treatment and survival, a study of 65 cases. Wang-Rodriguez J; Cross K; Gallagher S; Djahanban M; Armstrong JM; Wiedner N; Shapiro DH Mod Pathol; 2002 Aug; 15(8):853-61. PubMed ID: 12181271 [TBL] [Abstract][Full Text] [Related]
8. Correlations between HER2 Expression and Other Prognostic Factors in Breast Cancer: Inverse Relations with the Ki-67 Index and P53 Status. Payandeh M; Shahriari-Ahmadi A; Sadeghi M; Sadeghi E Asian Pac J Cancer Prev; 2016; 17(3):1015-8. PubMed ID: 27039719 [TBL] [Abstract][Full Text] [Related]
9. Ki67 index in breast cancer: correlation with other prognostic markers and potential in pakistani patients. Haroon S; Hashmi AA; Khurshid A; Kanpurwala MA; Mujtuba S; Malik B; Faridi N Asian Pac J Cancer Prev; 2013; 14(7):4353-8. PubMed ID: 23992002 [TBL] [Abstract][Full Text] [Related]
10. Prognostic value of breast cancer subtypes, Ki-67 proliferation index, age, and pathologic tumor characteristics on breast cancer survival in Caucasian women. Ferguson NL; Bell J; Heidel R; Lee S; Vanmeter S; Duncan L; Munsey B; Panella T; Orucevic A Breast J; 2013; 19(1):22-30. PubMed ID: 23240985 [TBL] [Abstract][Full Text] [Related]
11. Comparison of ER, PR and HER-2/neu (C-erb B 2) reactivity pattern with histologic grade, tumor size and lymph node status in breast cancer. Azizun-Nisa ; Bhurgri Y; Raza F; Kayani N Asian Pac J Cancer Prev; 2008; 9(4):553-6. PubMed ID: 19256737 [TBL] [Abstract][Full Text] [Related]
12. Expression of p53 Breast Cancer in Kurdish Women in the West of Iran: a Reverse Correlation with Lymph Node Metastasis. Payandeh M; Sadeghi M; Sadeghi E; Madani SH Asian Pac J Cancer Prev; 2016; 17(3):1261-4. PubMed ID: 27039757 [TBL] [Abstract][Full Text] [Related]
13. Retrospective analysis of estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor-2 (HER2), Ki67 changes and their clinical significance between primary breast cancer and metastatic tumors. Qi G; Zhang X; Gai X; Yan X PeerJ; 2024; 12():e17377. PubMed ID: 38766488 [TBL] [Abstract][Full Text] [Related]
14. Expression of Her2/neu, steroid receptors (ER and PR), Ki67 and p53 in invasive mammary ductal carcinoma associated with ductal carcinoma In Situ (DCIS) Versus invasive breast cancer alone. Mylonas I; Makovitzky J; Jeschke U; Briese V; Friese K; Gerber B Anticancer Res; 2005; 25(3A):1719-23. PubMed ID: 16033090 [TBL] [Abstract][Full Text] [Related]
15. Ki67 Frequency in Breast Cancers without Axillary Lymph Node Involvement and its Relation with Disease-free Survival. Shandiz FH; Shabahang H; Afzaljavan F; Sharifi N; Tavasoli A; Afzalaghaee M; Roshanzamir E; Pasdar A Asian Pac J Cancer Prev; 2016; 17(3):1347-50. PubMed ID: 27039770 [TBL] [Abstract][Full Text] [Related]
16. Discordance Rate in Estrogen Receptor, Progesterone Receptor, HER2 Status, and Ki67 Index Between Primary Unifocal and Multiple Homogenous Breast Carcinomas and Synchronous Axillary Lymph Node Metastases Have an Impact on Therapeutic Decision. Georgescu R; Boros M; Moncea D; Bauer O; Coros MF; Oprea A; Moldovan C; Podoleanu C; Stolnicu S Appl Immunohistochem Mol Morphol; 2018 Sep; 26(8):533-538. PubMed ID: 28099174 [TBL] [Abstract][Full Text] [Related]
17. The Case to Case Comparison of Hormone Receptors and HER2 Status between Primary Breast Cancer and Synchronous Axillary Lymph Node Metastasis. Sujarittanakarn S; Himakhun W; Worasawate W; Prasert W Asian Pac J Cancer Prev; 2020 Jun; 21(6):1559-1565. PubMed ID: 32592349 [TBL] [Abstract][Full Text] [Related]
18. Association of Histopathological Markers with Clinico- Pathological Factors in Mexican Women with Breast Cancer. Bandala C; De la Garza-Montano P; Cortes-Algara A; Cruz-Lopez J; Dominguez-Rubio R; Gonzalez-Lopez JN; Cardenas-Rodriguez N; Alfaro-Rodriguez A; Salcedo M; Floriano-Sanchez E; Lara-Padilla E Asian Pac J Cancer Prev; 2015; 16(18):8397-403. PubMed ID: 26745092 [TBL] [Abstract][Full Text] [Related]
19. Relation between Ki-67, ER, PR, Her2/neu, p21, EGFR, and TOP II-α expression in invasive ductal breast cancer patients and correlations with prognosis. Yan J; Liu XL; Han LZ; Xiao G; Li NL; Deng YN; Yin LC; Ling LJ; Yu XY; Tan CL; Huang XP; Liu LX Asian Pac J Cancer Prev; 2015; 16(2):823-9. PubMed ID: 25684532 [TBL] [Abstract][Full Text] [Related]
20. Expression of Ki67 and p53 Proteins: Breast Cancer Aggressivity Markers in Brazilian Young Patients. Bocchi M; Sousa Pereira N; Furuya RK; Motoori Fernandes CY; Losi-Guembarovski R; Vitiello GAF; Amarante MK; Watanabe MAE J Adolesc Young Adult Oncol; 2021 Aug; 10(4):379-388. PubMed ID: 32716670 [No Abstract] [Full Text] [Related] [Next] [New Search]